Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A. Aalkjær Danielsen"'
Publikováno v:
European Psychiatry, Vol 66, Pp S132-S133 (2023)
Introduction Antipsychotics (AP) are the primary pharmacological treatment for schizophrenia but increase the risk for diabetes, with recent meta-analyses indicating important differences between specific APs. However, these findings are based on ran
Externí odkaz:
https://doaj.org/article/1eebf30adfc545658e119d7b45bbd284
Autor:
Cecilie Marie Nielsen, Pernille Kølbæk, David Dines, Martin Locht Pedersen, Andreas Aalkjær Danielsen, Camilla Holmgård, Sanne Wissing, Anne-Mette Esbøl, Nina Friis Bak Fuglsang, Tuan Dang Nguyen, Ole Mors, Mark Opler, Christoph U Correll, Søren Dinesen Østergaard
Publikováno v:
Nielsen, C M, Kølbæk, P, Dines, D, Pedersen, M L, Danielsen, A A, Holmgård, C, Wissing, S, Esbøl, A-M, Fuglsang, N F B, Nguyen, T D, Mors, O, Opler, M, Correll, C U & Østergaard, S D 2022, ' Validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview among outpatients with schizophrenia ', Journal of Psychopharmacology, vol. 36, no. 11, pp. 1208-1217 . https://doi.org/10.1177/02698811221131992
Background: The six-item Positive and Negative Syndrome Scale (PANSS-6) is a measure of the severity of core symptoms of schizophrenia, which can be administered via the brief Simplified Negative and Positive Symptoms Interview (SNAPSI). A recent stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b4cf7b029218d765b4a9679fe163ca
https://pubmed.ncbi.nlm.nih.gov/36268705
https://pubmed.ncbi.nlm.nih.gov/36268705
Autor:
Annegrete Madsen, Laura Marie Aalkjaer Danielsen, Andreas Steenholt Niklassen, Mathias Hald, Alexander Fjaeldstad, Jesper Nørgaard Bech, Therese Ovesen
Publikováno v:
Madsen, A, Danielsen, L M A, Niklassen, A S, Hald, M, Fjaeldstad, A W, Bech, J N & Ovesen, T 2022, ' Chemosensory function and food preferences among haemodialysis patients ', Danish Medical Journal, vol. 69, no. 11, A08210644 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-09/a08210644_web-3.pdf >
Aarhus University
Madsen, A, Danielsen, L M A, Niklassen, A S, Hald, M, Fjaeldstad, A W, Bech, J N & Ovesen, T 2022, ' Chemosensory function and food preferences among haemodialysis patients ', Danish Medical Journal, vol. 69, no. 11, A08210644 .
Aarhus University
Madsen, A, Danielsen, L M A, Niklassen, A S, Hald, M, Fjaeldstad, A W, Bech, J N & Ovesen, T 2022, ' Chemosensory function and food preferences among haemodialysis patients ', Danish Medical Journal, vol. 69, no. 11, A08210644 .
INTRODUCTION: Malnutrition and disturbed sense of smell and taste frequently occur in patients treated with chronic haemodialysis. The common denominator between chemosensation and nutrition may be food preferences. Our aim was to investigate smell a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ad5f45445c7e40b02e7cf54cf055e8f6
https://pure.au.dk/portal/da/publications/chemosensory-function-and-food-preferences-among-haemodialysis-patients(cf8978cd-f03a-4514-9c1b-40c0c38ccf3a).html
https://pure.au.dk/portal/da/publications/chemosensory-function-and-food-preferences-among-haemodialysis-patients(cf8978cd-f03a-4514-9c1b-40c0c38ccf3a).html
Autor:
Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Heidi Storgaard, Filip K Knop, Mette Ødegaard Nielsen, Anders Mikael Sjödin, Ole Mors, Christoph U Correll, Claus Ekstrøm, Maj Vinberg, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Publikováno v:
Sass, M R, Danielsen, A A, Köhler-Forsberg, O, Storgaard, H, Knop, F K, Nielsen, M Ø, Sjödin, A M, Mors, O, Correll, C U, Ekstrøm, C, Vinberg, M, Nielsen, J, Vilsbøll, T & Fink-Jensen, A 2023, ' Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder : study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) ', BMJ Open, vol. 13, no. 1, e068652 . https://doi.org/10.1136/bmjopen-2022-068652
Sass, M R, Danielsen, A A, Köhler-Forsberg, O, Storgaard, H, Knop, F K, Nielsen, M Ø, Sjödin, A M, Mors, O, Correll, C U, Ekstrøm, C, Vinberg, M, Nielsen, J, Vilsbøll, T & Fink-Jensen, A 2023, ' Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder : study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) ', BMJ Open, vol. 13, no. 1, pp. e068652 . https://doi.org/10.1136/bmjopen-2022-068652
Sass, M R, Danielsen, A A, Köhler-Forsberg, O, Storgaard, H, Knop, F K, Nielsen, M Ø, Sjödin, A M, Mors, O, Correll, C U, Ekstrøm, C, Vinberg, M, Nielsen, J, Vilsbøll, T & Fink-Jensen, A 2023, ' Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) ', BMJ Open, vol. 13, no. 1, e068652 . https://doi.org/10.1136/bmjopen-2022-068652
Sass, M R, Danielsen, A A, Köhler-Forsberg, O, Storgaard, H, Knop, F K, Nielsen, M Ø, Sjödin, A M, Mors, O, Correll, C U, Ekstrøm, C, Vinberg, M, Nielsen, J, Vilsbøll, T & Fink-Jensen, A 2023, ' Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder : study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) ', BMJ Open, vol. 13, no. 1, pp. e068652 . https://doi.org/10.1136/bmjopen-2022-068652
Sass, M R, Danielsen, A A, Köhler-Forsberg, O, Storgaard, H, Knop, F K, Nielsen, M Ø, Sjödin, A M, Mors, O, Correll, C U, Ekstrøm, C, Vinberg, M, Nielsen, J, Vilsbøll, T & Fink-Jensen, A 2023, ' Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry) ', BMJ Open, vol. 13, no. 1, e068652 . https://doi.org/10.1136/bmjopen-2022-068652
IntroductionClozapine and olanzapine are some of the most effective antipsychotics, but both are associated with weight gain and relevant metabolic disturbances, including pre-diabetes and diabetes. Non-pharmacological/behavioural interventions have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fef96437e68655bf583d30679468a16
https://doi.org/10.1136/bmjopen-2022-068652
https://doi.org/10.1136/bmjopen-2022-068652
Autor:
Andreas Aalkjær Danielsen, Parker, Mark D., Soojung Lee, Boron, Walter F., Christian Aalkjær, Ebbe Boedtkjer
Publikováno v:
Aarhus University
Danielsen, A A, Parker, M D, Lee, S, Boron, W F, Aalkjær, C & Boedtkjer, E 2013, ' Splice cassette II of NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions ', Journal of Biological Chemistry, vol. 288, no. 12, pp. 8146-8155 .
Danielsen, A A, Parker, M D, Lee, S, Boron, W F, Aalkjær, C & Boedtkjer, E 2013, ' Splice cassette II of NBCn1 (slc4a7) interacts with calcineurin A: implications for transporter activity and intracellular pH control during rat artery contractions ', Journal of Biological Chemistry, vol. 288, no. 12, pp. 8146-8155 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2622599c75751e9c36325f240ad0ea15
https://pure.au.dk/portal/en/publications/splice-cassette-ii-of-nbcn1-slc4a7-interacts-with-calcineurin-a-implications-for-transporter-activity-and-intracellular-ph-control-during-rat-artery-contractions(cb82e971-ac8f-4919-a2e4-addec99189c5).html
https://pure.au.dk/portal/en/publications/splice-cassette-ii-of-nbcn1-slc4a7-interacts-with-calcineurin-a-implications-for-transporter-activity-and-intracellular-ph-control-during-rat-artery-contractions(cb82e971-ac8f-4919-a2e4-addec99189c5).html
Publikováno v:
European Psychiatry, Vol 67 (2024)
Abstract Background Clinical decision support systems (CDSS) based on machine-learning (ML) models are emerging within psychiatry. If patients do not trust this technology, its implementation may disrupt the patient-clinician relationship. Therefore
Externí odkaz:
https://doaj.org/article/fd72fd52a379441f8ab3be44336aaf73
Autor:
Jimmi Nielsen, Christoph U Correll, Tina Vilsbøll, Maj Vinberg, Claus Ekstrøm, Anders Fink-Jensen, Heidi Storgaard, Filip K Knop, Ole Mors, Marie Reeberg Sass, Andreas Aalkjær Danielsen, Ole Köhler-Forsberg, Mette Ødegaard Nielsen, Anders Mikael Sjödin
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Introduction Clozapine and olanzapine are some of the most effective antipsychotics, but both are associated with weight gain and relevant metabolic disturbances, including pre-diabetes and diabetes. Non-pharmacological/behavioural interventions have
Externí odkaz:
https://doaj.org/article/4cfda48f8fe44a2a8fb6e291b91659b4